Global cancer research in the post-pandemic world
Lancet Oncol
.
2021 Dec;22(12):1652-1654.
doi: 10.1016/S1470-2045(21)00602-1.
Authors
Deborah Mukherji
1
,
Raul Hernando Murillo
2
,
Mieke Van Hemelrijck
3
,
Verna Vanderpuye
4
,
Omar Shamieh
5
,
Julie Torode
6
,
C S Pramesh
7
,
Aasim Yusuf
8
,
Chris M Booth
9
,
Ajay Aggarwal
10
,
Richard Sullivan
6
;
COVID-19 and Cancer Task Force
Affiliations
1
Naef K Basile Cancer Institute, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon. Electronic address:
[email protected]
.
2
Pontificia Universidad Javeriana, Bogotá, Colombia.
3
Translational Oncology and Urology Research, Centre for Cancer, Society and Public Health, King's College London, London, UK.
4
National Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, Accra, Ghana.
5
Department of Palliative Care, King Hussein Cancer Center, Amman, Jordan.
6
Institute of Cancer Policy, Global Oncology Group, Centre for Cancer, Society and Public Health, King's College London, London, UK.
7
Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
8
Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore and Peshawar, Pakistan.
9
Division of Cancer Care and Epidemiology, Queen's Cancer Reserach Insitute, Kingston, ON, Canada.
10
London School of Hygiene and Tropical Medicine, London, UK.
PMID:
34856137
PMCID:
PMC8629493
DOI:
10.1016/S1470-2045(21)00602-1
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Biomedical Research
COVID-19*
Global Health
Humans
International Cooperation
Neoplasms / diagnosis*
Neoplasms / therapy*
Pandemics*